4//SEC Filing
McHale Duncan 4
Accession 0000899243-18-012419
CIK 0001694665other
Filed
May 9, 8:00 PM ET
Accepted
May 10, 6:05 PM ET
Size
5.4 KB
Accession
0000899243-18-012419
Insider Transaction Report
Form 4
McHale Duncan
Chief Medical Officer
Transactions
- Award
Stock Option
2018-05-08+79,052→ 79,052 totalExercise: $16.00Exp: 2028-05-08→ Common Stock (79,052 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the grant date and vests in equal quarterly installments over a three year period thereafter.
Documents
Issuer
Evelo Biosciences, Inc.
CIK 0001694665
Entity typeother
Related Parties
1- filerCIK 0001738896
Filing Metadata
- Form type
- 4
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 6:05 PM ET
- Size
- 5.4 KB